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Abstract
Accumulating epidemiological and clinical evidence shows that inflammation is an important risk factor for various 
human diseases. Thus, suppressing chronic inflammation has the potential to delay, prevent, and control various 
chronic diseases, including cerebrovascular, cardiovascular, joint, skin, pulmonary, blood, lymph, liver, pancreatic, 
and intestinal diseases. Various natural products from traditional Chinese medicine (TCM) have been shown to safely 
suppress proinflammatory pathways and control inflammation-associated disease. In vivo and/or in vitro studies have 
demonstrated that anti-inflammatory effects of TCM occur by inhibition of the expression of master transcription 
factors (for example, nuclear factor-κB (NF-κB)), pro-inflammatory cytokines (for example, tumor necrosis factor-α 
(TNF-α), chemokines (for example, chemokine (C-C motif) ligand (CCL)-24), intercellular adhesion molecule 
expression and pro-inflammatory mediators (for example, inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 
(COX2)). However, a handful of review articles have focused on the anti-inflammatory activities of TCM and explore 
their possible mechanisms of action. In this review, we summarize recent research attempting to identify the anti-
inflammatory constituents of TCM and their molecular targets that may create new opportunities for innovation in 
modern pharmacology. 
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Inflammation and chronic disease
Inflammation is known to contribute to physiological 
and pathological processes by the activation of the 
immune system, local vascular system, and various 
cells within the damaged tissue (Coussens and Werb, 
2002). Prolonged inflammation, known as chronic 
inflammation, is caused by a variety of factors, 
including microbial pathogen infection, physical, 
chemical, and surgical irritation, and/or wounding. 
The classical characteristics of inflammation are pain, 
swelling, edema, redness and heat (Mantovani, 2010). 
There is now growing evidence supporting the concept 
that chronic inflammation may affect many organ 
systems including skin, brain, colon, blood vessels, 
pancreas, joints, lung, and heart (Khatami, 2009).
Epidemiological  s tudies  have also revealed 
that chronic inflammation is causally linked to 
various human diseases, including cerebrovascular, 
cardiovascular, joint, cutaneous, pulmonary, blood, 
liver, and intestinal diseases as well as diabetes (Figure1). 
The inflammatory process leads to the up-regulation 
of a series of pro-inflammatory enzymes, cytokines, 
reactive oxygen/nitrogen species (RO/NS) and signaling 
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proteins in infected tissues and cells. Elevation in both 
the tissue and the serum levels of pro-inflammatory 
mediators predict an increased health risk at all stages 
of these diseases (Forrester and Bick-Forrester, 2005). 
Thus, blocking of inflammatory signaling is usually 
recognized as a potential therapeutic modality for 
chemoprevention.
TCM herbs as promising anti-
inflammatory agents
TCM has evolved over the past 5,000 years to prevent 
and manage human disease. The clinical recognition 
and diagnosis of disease in TCM are mainly based 
on the yin-yang and five elements theories (Lu et al., 
2009a). Traditionally, the two most common methods 
of applying herb treatments are to make a decoction 
(a strong tea that must be simmered for an hour or 
more) and to make large pills containing honey as a 
binding agent. However, modern herbs, developed to 
replace the standard Chinese preparations, come in two 
popular forms, namely, extract powders (or granules) 
and smooth (Wang et al., 2009). Herbs used in TCM 
and their active components have been demonstrated 
in many animal or cell culture models to inhibit 
inflammatory responses in different organs including 
the lung, esophagus, cerebrum, colon, skin, prostate, 
mammary glands, liver, pancreas, and lung (Pan et al., 
2011; Ichikawa et al., 2003; Yarosh et al., 2006). Table 
1 summarizes the various natural products derived from 
TCM herbs, which have been shown to safely suppress 
proinflammatory signaling pathways and to control 
inflammation- associated disease. 
Anti-inflammatory properties in chronic 
diseases and its possible mechanisms
Blood and lymph diseases
The human’s immune system is composed of 
organs such as the spleen and thymus along with 
lymph nodes and bone marrow that also contribute to 
the prevention of infection and disease by producing 
and storing specific immune cells (Schmid-Hempel, 
2005). Indeed, inflammation is an integral part of the 
immune system, but sometimes chronic inflammation 
becomes a pathophysiological process leading to 
disease development and progression (Handschin and 
Spiegelman, 2008).
Macrophages play a  central  role  in  chronic 
inflammation by mechanisms such as the overproduction 
of pro-inflammatory cytokines (tumor necrosis 
factor-α (TNF-α and interleukins (IL-6 and IL-1β) and 
generation of inflammatory mediators in response to 
microbial products (LPS, lipopolysaccharide), such 
as reactive oxygen species (ROS), prostaglandin E2 
(PGE2), nitric oxide (NO) and interferon-γ (IFN-γ). 
These mediators are potent activators of components 
of the pro-inflammatory signal transduction cascade, 
including NF-κB-inducing kinase, mitogen-activated 
protein kinase (MAPK),  and protein kinase C 
(PKC) (Pan et al., 2009a). 6-Jingerol, 6-shogaol, 
andrograpanin, phylligenin, tectorigenin, rhein, baicalin, 
berberine, naringenin, cimiracemate A, ligustilide and 
schicantherin A are bioactive substances in medicinal 
plants that have been reported to decrease LPS 
and/or IFN-γ-induced production of pro-inflammatory 
cytokines and mediators in macrophages and primary 
mouse splenocytes by down-regulation of MAPK and 
inhibition of PKC- mediated activation of downstream 
transcription factors NF-κB and activator protein 1 
(AP-1) (Lee et al., 2009c; Lim et al., 2008; Dugasani et 
al., 2010; Liu et al., 2008a;Ling et al., 2010; Zhang et 
al., 2010a; Pan et al., 2008; Luo et al., 2009; Li et al., 
2011b; Lin et al., 2008; Ho and Lin, 2008; Lin and Lin, 
2011; Hwang et al., 2011; Yang et al., 2009; Su et al., 
2011). Recently, evodiamine extracted from Evodiae 
Fructus (吳茱萸 wú zhū yú; the fruits of Evodia 
rutaecarpa), was also demonstrated to be effective in 
inhibiting the production of COX-2-mediated PGE2 and 
expression of iNOS through inhibition of PI3K/Akt/
p70S6K signaling and inhibition of hypoxia-inducible 
factor-1α (HIF-1α) accumulation in hypoxia-stimulated 
RAW 264.7 macrophages (Liu et al., 2009b). 
Figure 1. Human diseases linked with chronic inflammation
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Cerebrovascular diseases
Recent studies have shown that the severity of 
cerebrovascular disease, including Alzheimer ’s 
disease, Parkinson’s disease and cerebral ischemia, 
correlates with inflammation-mediated responses 
in neural cells (Britschgi and Wyss-Coray, 2007). 
Inflammation of the brain and central nervous system 
(CNS) are also mediated by the generation of various 
pro-inflammatory cytokines, including TNF-α, IL-
1β and IL-6 in microglia, astrocytes, ependymal cells, 
macrophages and mast cells (Rivest, 2009). Moreover, 
microglia activation is one of the causative factors 
in neuroinflammation, which results in brain damage 
during neurodegenerative disease. Previous studies 
have shown that luteolin, senkyunolide A, Z-ligustilide 
and Agrimoniae Herba possess anti-inflammatory 
properties by decreasing LPS-induced NO and PGE2 
production, by suppressing TNF-α, IL-1β, iNOS and 
COX-2 expression, and by blocking NF-κB activation 
in murine BV-2 microglial cells (Zhu et al., 2011b;Or 
et al., 2011b;Bae et al., 2010). In vivo  studies have 
shown that cholalic acid, hyodeoxycholalic acid and 
total glucosides of peony (TGP) can prevent cerebral 
ischemia and Alzheimer’s disease by inhibiting 
inflammatory cytokine (TNF-α, IL-1β and IL-6) 
production and down-regulating c-Jun N-terminal 
kinases (JNK), p-38 and MAPK extracellular signal-
regulated kinases (ERK) kinase3/6 (MEK3/6) 
phosphorylation (Huang et al., 2011; Hua et al., 2009).
Cardiovascular diseases
Recent studies have demonstrated that inflammatory 
responses  may cause  myocardia l  damage and 
atherosclerosis, leading causes of cardiovascular disease 
(CVD) (Libby, 2006). 
Tanshinone IIA and curcumin, substances with 
strong anti-inflammatory activity, have been shown to 
be effective in protecting against cardiac inflammation 
in in vitro  and LQYLYR models (RenHWDO 2010; Pari 
et al., 2008). Mito et al. (Mito, 2011) reported that 
the cardioprotective effects of curcumin are elicited 
through the inhibition of IL-1I, TNF-α, GATA-4 and 
NF-κB expression and may provide a novel therapeutic 
strategy for the treatment of autoimmune myocarditis. 
In addition, Salviae Miltiorrhizae Radix (丹參 dān shēn; 
the roots of Salvia miltiorrhiza  Bunge) preparations 
rich in tanshinone IIA were shown to reduce infarct 
size and improve cardiac apoptosis and inflammation 
by significantly enhancing Akt phosphorylation and 
suppressing NF-κB phosphorylation, myeloperoxidase 
(MPO) activity and production of inflammatory 
cytokines, such as TNF-α, and IL-6 (Zhang et al., 
2010b). Clinical studies have shown that vascular 
inflammation is the earliest event in the development of 
atherosclerosis (Izumimoto and Kawakami, 2011). The 
process involves stimulation of cholesterol and oxidized 
low density lipoprotein (ox-LDL) accumulation within 
the vessel wall and generation of oxidative free radicals, 
which activate vascular endothelial cells and enhance 
the adhesion of monocytes to them by promoting 
expression of endothelial adhesion molecules, including 
selectins, vascular cell adhesion molecule-1 (VCAM-1) 
and intracellular adhesion molecule-1 (ICAM-1) (Libby 
and Theroux, 2005). Once monocytes firmly attach to 
the surface of the endothelium under the influence of 
chemoattractants such as monocyte chemoattractant 
protein-1 (MCP-1), they transmigrate into the arterial 
intima and differentiate into macrophages. These 
macrophages proliferate and amplify the inflammatory 
response through the secretion of numerous growth 
factors, adhesion molecules, pro-inflammatory cytokines 
(IL-6, IL-1β and TNF-α) and matrix metalloproteinases 
(MMPs) (Packard and Libby, 2008). In addition, the 
toll-like receptors (TLRs) TLR-2 and TLR-4 also play 
an important role in innate immune and inflammatory 
responses, and several reports have demonstrated 
the expression of TLR2 and TLR4 in atherosclerotic 
lesions (Schoneveld et al., 2008). TGP, ginsenoside, 
ginkgolide B, monacolin K and glycyrrhetinic acid 
have been shown in experimental animal studies and in 
vitro studies of human umbilical vein endothelial cells 
(HUVEC) to significantly attenuate the development of 
atherosclerotic disease by decreasing ROS generation, 
reducing expression of adhesion molecules, MMP-2 and 
pro-inflammatory mediators and increasing macrophage 
migration inhibitory factor (MIF) levels (Li et al., 2009; 
Chang et al., 2010; Xie et al., 2011; Li et al., 2008; Li et 
al., 2011a; Liu et al., 2008b; Liu et al., 2010b).
Pancreatic disease
Mounting evidence suggests that oxidative stress and 
chronic inflammation play an important role in obesity-
related metabolic disorders such as type 2 diabetes 
(Hotamisligil, 2006). However, type 1 diabetes, one of 
the most common autoimmune diseases, is caused by 
T cell- mediated destruction of pancreatic beta cells 
(Kalousova et al., 2004). More and more evidence 
indicates that the anti-inflammatory effects of TCM 
may contribute to their antidiabetic action (Xie and Du, 
2011).
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Recent studies have shown that berberine can 
ameliorate type 1 diabetes and decrease the expression 
of Th17 cytokines in nonobese diabetic (NOD) mice 
via suppression of Th17 and Th1 differentiation. 
Berberine inhibited Th1 differentiation by decreasing 
the activity of STAT1 and STAT4 through suppression 
of p38 MAPK/JNK activity, but down-regulated 
Th17 differentiation through activation of ERK1/2 
and reduction in the levels of STAT3 phosphorylation 
and retinoic acid-related orphan receptor γt (RORγt) 
expression (Cui et al., 2009). 
Recently, the active principles in Astragali Radix (黃
耆 huáng qí) (calycosin, calycosin-7-β-D-glucoside, 
ononin, calycosin and formononetin) that inhibit pro-
inflammatory cytokine production were identified. 
XuHWDO(Xu et al., 2011) have reported that calycosin 
can inhibit advanced glycation end products (AGEs)-
induced macrophage migration and adhesion to 
endothelial cells; calycosin also can relieve local 
inflammation by reducing expression of transforming 
growth factor-β1(TGF-β1), ICAM-1, p-ERK 1/2, p-NF-
κB and receptor for advanced glycation end products 
(RAGE) and by increasing expression of the estrogen 
receptor in HUVECs (Xu et al., 2011). In another study, 
it was demonstrated that four natural compounds from 
Astragali Radix (黃耆 huáng qí) with anti-diabetic and 
insulin sensitizing effects can reduce the secretion of 
pro-inflammatory cytokines (TNF-α, IL-6 and MCP-1) 
and expression levels of inflammatory cell markers 
(CD68 and F4/80) and increase the level of agrinase I 
(Hoo et al., 2010).
This major increase in morbidity and mortality of 
diabetes is due to the development of both macro- and 
micro-vascular complications such as are commonly 
found in diabetic patients with foot ulcers (Levin, 2002). 
Previous scientific studies reported that Rehmanniae 
Radix (地黃 dì huáng) was effective in promoting 
diabetic foot ulcer healing, angiogenesis, and tissue 
regeneration and in inhibiting inflammation through 
induction of vascular endothelial growth factor (VEGF) 
expression, reduction of LPS-induced NO production, 
stimulation of human fibroblast cell (Hs27) proliferation 
and promotion of HUVEC cell migration and tube 
formation (Lau et al., 2009; Tam et al., 2011).
Intestinal disease
The major forms of inflammatory bowel disease 
(IBD), i.e., Crohn's disease and ulcerative colitis (UC), 
are chronic relapsing inflammatory conditions of the 
gastrointestinal tract, resulting from impairment of 
intestinal epithelial barrier function and subsequent 
defects in adaptive immunity (Tsianos and Katsanos, 
2009). Increasing evidence demonstrates that infiltration 
and migration of innate immune cells depends on 
production of pro-inflammatory cytokines, chemokines 
and adhesion molecules (Jose et al., 2006). In addition, 
the inflammatory reaction involves complex interactions 
between immune cells and endothelial cells (ECs), 
the monolayer between blood and tissue (Bouguen 
et al., 2011). Therefore, restoration of the balance 
between pro- and anti-inflammatory cytokines may 
be a promising strategy for the treatment of IBD. 
Recent studies have shown that mollugin inhibits TNF-Į 
-induced inflammatory responses and chemotaxis in 
HT-29 cells and U937 cells through inhibition of NF-
țB activation and decreased MCP-1, IL-8 and ICAM-1 
expression (Kim et al., 2009). In another model it has 
also been found that matrine, berberine, hypaconitine 
and skimmianine could inhibit the LPS-stimulated 
inflammatory reaction by improving NO-dependent 
vasomotion and inhibiting expression of inflammatory 
mediator (IL-6, IL-8, soluble ICAM-1, TNF-α LBP, and 
PGE2) (Zhang et al., 2011;Suo et al., 2009). The colitis 
model in rats has indicated that berberine, hypaconitine, 
skimmianine, oxymatrine and rhubarbs can ameliorate 
acetic acid- and 2,4,6-trinitrobenzene sulfonic acid 
(TNBS)-induced colitis and bowel pain via decreases 
in TNFα, LBP, IL-12, TLR-4 and NF-κB activation and 
increases in the IL-10 level, resulting in an improved 
balance of Th1 and Th2 cells (Zhang et al., 2011; Fan et 
al., 2008; Liu et al., 2009a).
Pulmonary diseases
Respiratory epithelium plays a key role in airway 
inflammatory disease, including asthma, acute and 
chronic microbial infections, and obstructive pulmonary 
disease by the production of numerous cytokines, 
chemokines, inflammatory enzymes, and adhesion 
molecules (Iwamoto, 2003). Importantly, balance of 
Th1-Th2 cytokine secretion has been suggested as 
necessary to maintain healthy immune homeostasis. 
Imbalance has been hypothesized to underlie allergic 
asthma through a shift in immune responses from 
a Th1 (IFN-γ) pattern toward a Th2 (IL-4, IL-5, 
and IL-13) profile, which promotes IgE production, 
eosinophilic inflammation, activation and survival, and 
enhanced airway smooth muscle contractility (Busse 
and Rosenwasser, 2003). Previous studies also suggest 
that lung epithelial cells are involved in inflammatory 
processes by recruiting immune cells and producing pro-
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inflammatory cytokines, resulting in amplification of the 
inflammatory signal (Lee et al., 2007). Recent studies 
showed that ursolic acid, triptolide and Viticis Fructus 
(蔓荊子 màn jīng zǐ; the fruits of Vitex rotundifolia ) 
extract could suppress Th2 cell proliferation, eosinophil 
migration and neutrophilic inflammation by down-
regulation of cytokines, chemokines and cell adhesion 
molecules (Lee et al., 2007; Lee et al., 2008; Hoyle 
et al., 2010; Sohn et al., 2009). We found that Visci 
Ramus (槲寄生 hú jì shēng; the dried stem, with 
leaf Viscum coloratum), Ganoderma (靈芝 líng zhī; 
Ganoderma lucidum), Sophorae Flavescentis Radix (苦
參 kǔ shēn) and Glycyrrhizae Radix (甘草 gān cǎo) 
extract potently inhibited airway hyperresponsiveness 
(AHR) and reduced eosinophil infiltration of the lungs 
in ovalbumin (OVA)-sensitized mice by reducing levels 
of IgE, CCLs (CCL11 and CCL24) and Th2-associated 
cytokines (IL-5, IL-4 and IL-13), and by increasing 
IFN-IIsecretion (Busse et al., 2010; Shen et al., 2011). 
Polyphenol rich extracts from officinal magnolia bark 
(厚朴 hòu pò) and baicalin were also shown to alleviate 
pneumonia by decreasing the level of NO, IL-6, TNF-α 
and ICAM-1 and reducing NF-κB and Toll like receptor 
(TLR)-3 expression in Pneumocystis carinii  and 
influenza virus A (IVA)-infected lung tissue (Wu et al., 
2011; Zhou and Zhou, 2009).
Joint diseases
Rheumatoid arthritis (RA) is a systemic and chronic 
inflammatory autoimmune disorder characterized by 
synovial hyperplasia, inflammatory cell infiltration 
and angiogenesis, which ultimately lead to cartilage 
erosion and articular destruction (Leff, 2006). Several 
inflammatory cytokines, such as TNF-α, IL-1β, IL-6, 
IL-33 and rheumatoid factor (RF) not only play 
important roles in the chronic inflammation of human 
RA, but are also associated with various manifestations 
of inflammation-related angiogenesis (Marrelli et al., 
2011).
In the rat model of arthritis, the extract of Arisaematis 
Rhizoma (天南星 tiān nán xīng; the root of Arisaema 
rhizomatum), scopolin and kirenol inhibited paw and 
joint swelling by suppressing inflammatory cytokines 
and NO production, inhibiting VEGF and fibroblast 
growth factor (FGF-2) expression and up-regulating 
Annexin-1 which interacts with NF-κB to inhibit NF-
κB activity (Chunxia et al., 2011; Wang et al., 2011; 
Pan et al., 2009b). LiuHWDO (Liu et al., 2010a) also 
demonstrated that icariin can protect chondrocytes from 
LPS-induced inflammation and extracellular matrix 
degradation through inhibition of NO, MMP, iNOS 
and COX-2 expression. The direct anti-inflammatory 
and analgesic effects of TCM were observed in animal 
models of both acute and subacute inflammation, such 
as formalin-induced paw licking, carrageenan-induced 
paw edema, cotton pellet-induced granuloma, acetic 
acid-induced permeability, xylene-induced ear edema, 
collagen-induced arthritis, complete Freund’s adjuvant 
(CFA)-induced joint inflammation and thermally 
induced pain.
Skin diseases
As the primary interface between the body and 
the external environment, the skin provides the first 
line of defense against traumatic injury and infection 
by microbial pathogens. Besides its properties as a 
physical barrier, the skin has many active defense 
mechanisms and regulation of these mechanisms is 
important because inappropriate or misdirected immune 
activity is implicated in the pathogenesis of a large 
variety of inflammatory skin diseases. High levels of 
pro-inflammatory cytokines and ROS are proposed 
to contribute to the pathophysiological mechanisms 
(Numerof et al., 2005). Lee et al . (Lee et al., 2009a; 
Lee et al., 2009b) found anti-inflammatory effects 
of the extract of wild chrysanthemum (野菊 yě jú; 
Chrysanthemum indicum , CIE) and Asparagi Radix (天
門冬 tiān mén dōng; Asparagus cochinchinensis Merrill, 
ACE) in 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-
induced mouse ear edema and acetic acid-induced 
vascular permeability models. CIE and ACE showed 
potent inhibitory activity against topical edema of the 
mouse ear, leading to substantial reductions in skin 
thickness and tissue weight, inflammatory cytokine 
production (TNF-α and IL-1β, neutrophil-mediated 
MPO activity, and various histopathological indicators.
Liver disease
Most  acu te  and  ch ron ic  l ive r  d i seases  a re 
characterized by the presence of inflammatory and 
oxidative stress processes with enhanced expression of 
various pro-inflammatory cytokines and lipid mediators 
(Ferre and Claria, 2006;Tilg et al., 2006). In the non-
alcoholic steatohepatitis (NASH) model, keishi-
bukuryo-gan and Qu Yu Hua Tan Tong Luo decoctions 
have been found to relieve lipid peroxidation and 
inflammation of the liver by down-regulation of TNF-α, 
IL-8, cholesterol, triglycerides (TGs) and MDA levels 
and up-regulation of superoxide dismutase (SOD) 
activity (Fujimoto et al., 2010; Zhang et al., 2008).
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Conclusion
Strong direct evidence suggests that chronic 
inflammation promotes development of numerous 
human diseases such as Alzheimer’s, atherosclerosis, 
arthritis, asthma, diabetes and IBD. The Chinese herbs 
investigated are mostly qi supplementation (補氣 bǔ 
qì), heat-clearing (清熱 qīng rè ) and toxin-resolving 
(解毒 jiě dú) drugs, as described previously in the 
theory of TCM (Xie and Du, 2011). TCM has a long 
history of human use, and the main active components 
recorded and identified, in heat-clearing and detoxifying 
Chinese herbs usually have widespread pharmacological 
effects including anti-inflammatory actions (Ren et 
al., 1994). Clinical trials have also demonstrated the 
effectiveness of TCM for the prevention and therapy 
of many chronic inflammatory diseases, and the related 
mechanisms have also been identified. Therefore, in 
this article, we systemically reviewed the evidence for 
the efficacy of anti-inflammatory products used in TCM 
in the treatment of inflammatory processes associated 
with various chronic diseases and shared their known 
mechanisms of action. 
It is clear that natural bioactive compounds from 
herbs used in TCM can interfere with multiple cell 
signaling pathways and have multiple targets within 
the cells. These mechanisms include (a) modulation of 
inflammatory signal transduction pathways linked to 
NF-țB, AP-1, PI3K/Akt, MAPKs, STATs, and TLRs, 
(b) induction of antioxidant enzymes such as SOD, 
glutathione peroxidase (GPx) and glutathione reductase 
(GRx), (c) reduction of inflammatory molecule 
production including iNOS, COX-2, NO and PGE2 (d) 
diminished recruitment and activation of inflammatory 
cells, (e) altered regulation of cellular functions and 
(f) changes in the balance of Th1 and Th2 cell-derived 
cytokines (Figure1). Besides their influence on the 
regulation of intracellular signaling pathways, the active 
components from TCM may also inhibit expression of 
growth factors (VEGF, FGF-2 and TGF-β1) and MMPs, 
which are important cofactors for angiogenesis, wound 
repair and tissue regeneration.
This information adds to the body of evidence 
indicating that the products of TCM, because of their 
safety and anti-inflammatory efficacy, may have a 
potential role in the prevention and treatment of chronic 
inflammatory disease (Figure 2). Furthermore, extensive 
research is needed concerning the influence of active 
herbal products on the pathological, immunological, 
biochemical and molecular biology-related aspects 
of disease processes, which may ultimately lead to 
enhanced formulations for chemoprevention.
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Figure 2. Effects of traditional Chinese medicine (TCM) mediated by the molecular mechanisms of anti-inflammatory action
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Table 1. Anti-inflammatory effects of the active components from TCM herbs 
Group of diseases
(target organ) Chinese herbs
Experimental models 
Studied type (Dose) Mechanism(s) of action (refs)
Blood and lymph 
diseases Origin (pinyin)
Effective ingredient/
Decoction
a.  LPS-stimulated macrophage 
cells (RAW264.7) (20-80 μM)
b.  LPS-induced RAW 264.7 
cells (1-6 μM)
a.  Decreases inducible nitric oxide synthase 
(iNOS) and tumor necrosis factor-α(TNF-α) 
expression by blocking nuclear factor-κB 
(NF-κB) and protein kinase C-α (PKC-α) 
signaling (Lee et al., 2009c)
b.  Reduces prostaglandin E2 (PGE2) and nitric 
oxide (NO) production (Dugasani et al., 2010)
LPS-stimulated bone marrow-
derived murine macrophage 
cells (1.5-90 μM)
Inhibits iNOS, TNF-Į, interleukin (IL)-6 and 
IL-12p70 expression and NO production by 
down-regulation of p38 mitogen-activated 
protein kinase (MAPKs) signaling pathways 
(Liu et al., 2008a)
a.  LPS-stimulated RAW264.7 
cells (1-100 μM)
b.  λ-Carrageenan-induced paw 
edema in mice (12.5-100 
mg/kg)
a.  Inhibits cyclooxygenase-2 (COX-2)-
mediated PGE2 and iNOS-mediated NO 
synthesis by down-regulation of NF-κB 
signaling pathways 
b.  Suppresses mouse carrageenan-induced paw 
edema (Lim et al., 2008)
Mori Ramulus was 
extracted by EtoAc, 
n-BuOH and chloroform
LPS/Interferon-gamma (IFN-γ ) 
stimulated macrophage cells
EtOAc and n-BuOH extractions: inhibits NO 
production (Ling et al., 2010)
LPS/ IFN-γ stimulated 
RAW264.7 cells (50-100 μM)
Decreases NO, IL-1β and PGE2 production, 
and iNOS and COX-2 protein expression 
by blocking of NF-κB activation (Pan et al., 
2008)
One cembrane-type 
diterpenoid
Two benzenoids 
Five flavonoids 
Six phenyl propanoids 
LPS/ IFN-γ stimulated 
peritoneal excluded macrophage 
cells (2-40 μM)
Decreases NO, TNF-Į andIL-12 production 
(Rao et al., 2009)
Triterpenes and 
polysaccharides were 
extracted by 95% EtOH 
from G. lucidum  (GLT) 
a.  LPS-induced RAW264.7 cells 
(3-50 (μg/mL)
b.  LPS-induced endotoxemic 
mice (12 mg/kg)
a.  Reduces TNF-α, IL-6, PGE2 and NO 
production, and protein expressions of iNOS 
and COX-2 by inhibiting ERK and JNK-
mediated 
b.  NF-κB and AP-1 activation. Inhibits 
the production of TNF-α and IL-6 
(Dudhgaonkar et al., 2009)
a.  LPS-stimulated RAW264.7 
cells (0.3-10 μM)
b.  Intraperitoneal-injection of  
LPS (3.2 mg/kg) in male SD 
rats (oral administration, 3.34 
g/kg)
Decreases NO production in vitro and in vivo 
(Xu, 2006)
Hypoxia (1% O2)-induced 
RAW264.7 cells 
(0.3-3 μM)
Represses hypoxia-induced COX-2-mediated 
PGE2 production and iNOS expression by 
down-regulation of p-Akt and p-p70S6K-
mediated HIF-1α translational process (Liu et 
al., 2009b)
LPS-stimulated primary mouse 
splenocytes
(Berberine: 0.8-3.3 μM)
(Naringenin: 18-70 μM)
Inhibits IL-6/IL-10 or TNF-α/IL-10 ratios (Lin 
and Lin, 2011)
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Group of diseases
(target organ) Chinese herbs
Experimental models 
Studied type (Dose) Mechanism(s) of action (refs)
Houttuynia cordata 
Thunb.  (HC) essential oil 
were extracted by steam 
distillation
LPS-induced mouse peritoneal 
macrophages
(0.01-100 μg/mL)
Decreases PGE2 production, COX-2 activity, 
and COX-2 gene and protein expression (Li et 
al., 2011b)
LPS-induced human primary 
blood macrophages
(140 μM)
Inhibits TNF-α production by down-regulation 
of ERK and NF-κB activities (Yang et al., 
2009)
Acanthopanax senticosus
extract (ASE)
LPS/ IFN-γ-stimulated 
RAW264.7 cells
(100-1000 μg/mL)
Suppresses iNOS and NO production through 
the inhibition of intracellular peroxides levels 
and NF-κB activity (Lin et al., 2008)
S. hemiphyllum sulfated 
polysaccharide extract
(SHSP)
LPS-stimulated RAW264.7 cells 
(1-5 mg/mL)
Reduces TNF-T, IL-6, IL-1β and NO 
production, and RNA expressions of IL-1β, 
iNOS and COX-2 by down-regulation of NF-
κB translocation (Hwang et al., 2011)
Citrus fruit peels were 
extracted by heat 
treatment
(naringin, hesperidin,
nobiletin and tangeretin)
LPS-stimulated RAW264.7 cells 
(0.5-4 mg/mL)
Inhibits NO production, and iNOS gene 
expression (Ho and Lin, 2008)
LPS-stimulated RAW264.7 cells 
(5-250 μM)
Suppresses NO, PGE2 and TNF-α production 
by blocking the activation of p38MAPK, 
extracellular signal-regulated kinase 
(ERK1/2), c-Jun N-terminal kinase (JNK) and 
the downstream transcription factors AP-1 and 
NF-κB (Zhu et al., 2011b)
LPS-stimulated RAW264.7 cells 
(0.5-25 mg/mL)
Reduces TNF-α, IL-6, 3*(and NO 
production, and protein expressions of iNOS, 
and COX-2 by blocking NF-κB and MAPKs 
(JNK, p-38 and ERK) signaling (Ci et al., 
2010)
LPS/ IFN-γ -stimulated 
RAW264.7 cells
Suppresses NO production, iNOS, COX-2, 
IL-1β, IL-6 levels and increases peroxisome 
proliferator-activated receptor gamma 
(PPAR-γ) expression through ERK/ pathway 
(Zhang et al., 2010a)
Total alkaloids from 
Radix Linderae (TARL)
LPS-stimulated RAW264.7 cells 
(10-100 mg/mL)
Prevents NO, IL-1β and TNF-α production, 
and mRNA expressions of 
iNOS, IL-1β and TNF-α by blocking MAPKs 
(p-38 and ERK) and NF-κB p65 protein 
phosphorylation (Luo et al., 2009)
Cerebrovascular diseases (brain and neuron)
Neuroinflammation LPS-stimulated murine BV2 
microglia
(10-50 μM)
Suppresses NO and PGE2 production, and 
TNF-TTTiNOS, COX-2 and IL-1β expression 
by blocking the activation of NF-κB signaling 
(Zhu et al., 2011a)
Alzheimer's disease Valeriana amurensis was 
extracted by 50% EtOH
Alzheimer's disease model rats' 
brain
Reduces iNOS, COX-2 and IκB-αBlevels 
(Zhang et al., 2010c)
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Group of diseases
(target organ) Chinese herbs
Experimental models 
Studied type (Dose) Mechanism(s) of action (refs)
Alzheimer's disease Total glucosides of 
paeony (TGP)
Fibrillar Abeta42 induced 
Alzheimer's disease (AD)
Decreases IL-1β, IL-6, p-p38, p-c-Jun 
N-terminal kinases (JNK) and  MAP kinase 
kinase3/6 (MEK3/6) protein expressions 
(Huang et al., 2011)
Brain inflammation LPS-induced BV2 microglial 
cells (0.01-1mg/mL)
Suppresses TNF-Į, IL-1β, IL-6 production and 
iNOS expression (Bae et al., 2010)
Neuroinflammation LPS-stimulated murine BV-2 
microglial cells and human 
peripheral blood monocyte 
derived macrophages
(25-50 μg/mL)
Increases the degradation of TNF-α and iNOS 
mRNA expressions and reduce TNF-α half life 
(Or et al., 2011a)
Focal Cerebral 
Ischemia
Cerebral ischemia model in rat 
brain (21 mg/kg)
Decreases TNF-α and IL-1β levels (Hua et al., 
2009)
Cardiovascular diseases (heart)
Autoimmune 
myocarditis
Cardiac myosin-induced 
experimental autoimmune 
myocarditis (EAM)
(50 mg/kg/d)
Against cardiac inflammation through 
suppression of IL-1β, TNF-α,  GATA-4 and 
NF-κB expresses (Mito, 2011)
Cardiac inflammation 1. Myocardial ischaemia 
/reperfusion (I/R) injury in 
diabetic rats
(5 mg/kg)
Decreases cardiac inflammation by enhancing 
PI3K/Akt pathway, suppressing NF-κB 
p65 protein phosphorylation and reducing 
of  myeloperoxidase (MPO) activity and 
cytokines production including TNF-α and 
IL-6 (Zhang et al., 2010b)
Atherosclerosis Rhubarb were extracted 
by water
Atherosclerotic animal model
(50 mg/kg/day)
Inhibits toll-like receptor (TLR)-2, TLR4 and 
NF-κB mRNA and protein expressions (Liu et 
al., 2008b)
Atherosclerosis Total glucosides of 
paeony (TGP) capsules: 
paeoniflorin (40 
%),hydroxy-paeoniflorin 
(10 %) and other (50 %)
Vitamin D and cholesterol 
induced atherosclerosis model in 
rats (120 or 240 mg/kg)
Inhibits the serum level of inflammatory 
cytokines ( IL-6, and TNF-α) (Li et al., 2011a)
Chronic vascular 
inflammation
Oxidized low-density 
lipoprotein (ox-LDL) stimulated 
human umbilical vein 
endothelial cells (HUVECs) 
(0.1-0.3 mg/mL)
Reduces intercellular adhesion molecule-1 
(ICAM-1) expression,  NF-κB signaling and 
inhibiting reactive oxygen species (ROS) 
generation (Li et al., 2009)
Atherosclerosis TNF-T-activated human 
umbilical vein endothelial
cells (HUVEC)
(50 μM)
Inhibits ICAM-1 expression, leading to a 
decrease in adherent monocytes (THP-1) to 
HUVEC by inhibition of TNF-α-activated 
JNK/c-Jun and NF-κB signaling pathways 
(Chang et al., 2010)
Vascular endothelial 
lesion
L-methionine (3%) induced SD 
male rats (0.8 mg/kg/day)
Decreases iNOS and COX-2 expression (Li et 
al., 2008)
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Experimental models 
Studied type (Dose) Mechanism(s) of action (refs)
Atherogenesis Zymosan (10 mg/kg)
high-cholesterol diet induced 
chronic inflammation in rabbits
(120 mg/kg/day by oral gavage)
Reduces monocyte chemoattactant protein-1 
(MCP-)1 and NF-κB mRNA expressions and 
serum level of IL-6 (Liu et al., 2010b)
Atherosclerosis Angiotensin II (AngII)-induced  
apolipoprotein E-deficient 
(ApoE−/−) mice 
(200 mg/kg/day by oral gavage)
Increases of serum macrophage migration 
inhibitory factor (MIF) and  reductions 
of serum total cholesterol, intercellular 
adhesion molecule- 1(ICAM-1), vascular 
cell adhesion molecule-1 (VCAM-1), matrix 
metalloproteinase (MMP)-2 (Xie et al., 2011)
Pancreas disease
1. Type 1 diabetes
2. Inflammatory 
responses and insulin 
resistance
1.  B and T cells were isolated 
from nonobese diabetic 
(NOD) mice (200 mg/kg)
2.  Palmitate (PA) stimulated 
HepG2 cells (0.1-10 μM)
1-1.  Decreases Th17 cytokine secretion and 
differentiation by activation of ERK1/2 
and down-regulation of p-STAT3 and 
RORγt expression 
1-2.  Reduces Th1 cytokine secretion and 
differentiation by inhibition of p38 
MAPK and JNK activation and down-
regulation of STAT1 and STAT4 activities 
(Cui et al., 2009)
2.  Inhibits IL-6, and TNF-α production, 
modifies of insulin receptor substrate-1 
(IRS-1) and downstream Akt (Lou et al., 
2010)
Diabetic nephropathy Advanced glycation end 
products (AGEs) -induced 
macrophages infiltration in 
HUVECs (10−8 M)
Reduces macrophage migration and adhesion 
to endothelial cells by down-regulation of 
transforming growth factor-b1(TGF-β1), 
ICAM-1 and receptor for advanced glycation 
end products (RAGE) expressions; increase 
estrogen receptor expression and inhibits 
p-ERK1/2 and p-NF-κB expression (Xu et al., 
2011)
Obesity-related
metabolic disorders:
diabetic
insulin resistance 
hypertriglyceridemia
a.  Human THP-1 macrophages 
(5-10 μg/mL)
b.  LPS-induced mouse RAW-
Blue macrophage  (10-20 
μg/mL)
c.  C57BL/KsJ db/db diabetic 
mice (2g/kg/day)
a and b. Reduced the secretion of pro-
inflammatory cytokines (TNF-α, IL-6 and 
MCP-1) 
c. Decreases CD68 and F4/80 mRNA 
expression and pro-inflammatory cytokines 
(MCP-1, TNF-α and IL-6), and increases 
arginase I in epididymal adipose tissue (Hoo et 
al., 2010)
Diabetic 
complications :
foot ulcer
1.  Radix rehmanniae 
(RR)  extract
2.  2-herb formula (NF3) 
was extracted from 
radix astragali (RA) 
and RR
1-a.  Streptozotocin (STZ) 
-induced diabetic in rats
1-b.  Carrageenan-induced 
inflammation in rats  
(1.85 mg/kg)
2.  Streptozotocin (STZ) 
-induced diabetic in rats  
(0.98 g/kg)
1.  Enhances vascular endothelial growth factor 
(VEGF) expression (Lau et al., 2009)
2.  Reduction of wound area and LPS-induced 
NO production, stimulation of human 
fibroblast cells (Hs27) proliferation and 
promotion of HUVEC cell migration and 
tube formation (Tam et al., 2011)
Intestinal disease 
Colon inflammation a. TNF-α-induced HT-29
human colon epithelial cells
b. TNF-α-induced attachment of 
U937 monocytic cells to HT-29 
cells (20 μM)
a.  Inhibits MCP-1 and IL-8, and ICAM-
mRNA expression by blocking  NF-κB 
activation 
b.  Suppress TNF-Į-induced U937 monocytic 
cell adhesion to HT-29 colonic epithelial 
cells (Kim et al., 2009)
Colon inflammation LPS-stimulated second 
generation rat intestinal 
microvascular endothelial cells 
(RIMECs) (50 μg/mL)
Inhibits IL-6, IL-8, and soluble ICAM-1 
production and improvHV NO-dependent 
vasomotion (Suo et al., 2009)
  18
       Pan et al . / Journal of Traditional and Complementary Medicine 1 (2011) 8-24
Group of diseases
(target organ) Chinese herbs
Experimental models 
Studied type (Dose) Mechanism(s) of action (refs)
Ulcerative colitis Berberine, hypaconitine 
and skimmianine from 
Fructus Mume pill 
(FMP)
a.  Trinitrobenzene-sulfonic acid 
induced ulcerative colitis in 
rats
b.  Xylene-induced acute edema 
(6-27 mg/kg/day)
c.  Acetic acid-induced writhing 
(6-27 mg/kg/day)
d.  LPS-stimulated HT-29 cell 
(5-30 μM)
a.  Inhibits TNF-α, lipopolysaccharide (LPS) 
binding protein (LBP) production and TLR4 
and NF-κB expression
b  and c. Relieving acetic acid-induced bowel 
pain and xylene-induced acute exudative 
edema 
d.  Suppresses TNF-TTTLBP and PGE2 levels 
(Zhang et al., 2011)
Immunoregulatory 
effects and colitis
Rhubarbs were extracted 
the polysaccharides-
enriched fractions
Trinitrobenzene-sulfonic acid 
(TNBS)-induced colitis in rats
(200 mg/kg/day)
Decreases TLR4 activation and promoted the 
balance of Th1 and Th2 polarization, inhibited 
NF-κB activity. (Liu et al., 2009a)
Immunoregulatory 
effects and colitis
TNBS-induced colitis in rats
(63 mg/kg/day)
Regulating the unbalance of Th1 and Th2 
cytokines secretion via  decreases IL-2 
level and increases IL-10 level and NF-κB 
expression
(Fan et al., 2008)
Pulmonary diseases 
Chronic allergic 
inflammation 
and asthma
Cordyceps extract Peripheral blood mononuclear 
cells (PBMCs) (10-20 μg/mL)
Inhibits the proliferation and differentiation 
of Th2 cells and reduce IL-4 and GATA-3 
expression and increasing the content of 
IL-10 and expression forkhead/winged-helix 
transcription factor-3 (Foxp3) (Sun et al., 
2010)
Allergic diseases and 
asthma
Vitex rotundifolia was 
extracted by distilled 
water
TNF-α, IL-4 and IL-1β 
stimulated A549 human alveolar 
epithelial cells (0.1-1 μg/mL)
Suppresses eotaxin secretion, eosinophil 
migration and down-regulated inflammation 
and cell adhesion-related genes (ICAM, 
VCAM, IL-8, NOS 2A and IL-5RA) by 
mitogen-activated protein kinase pathway 
(Sohn et al., 2009)
Airway inflammation Partially purified extract 
(PPE-SVC) and viscolin 
were extracted from 
Viscum coloratum Nakai
Ovalbumin (OVA)-sensitized 
mice (5 mg/kg)
Suppresses airway hyperresponsiveness 
(AHR) and eosinophil infiltration of the 
lungs via reducing levels of chemokine (C-C 
motif) ligand (CCL) (CCL11 and CCL24), 
IgE and Th2-associated cytokines (IL-5) in 
bronchoalveolar lavage fluid (BALF) (Shen et 
al., 2011)
Lung inflammation LPS-stimulated A549 cells
(50 μg/mL)
Inhibites IL-8 production, NF-κB activation, 
and iNOS mRNA Expression (Lee et al., 
2008)
Acute lung injury
Lung inflammation
a.  Gq-coupled tachykinin 1 
receptor with substance P or  
TNF-  stimulated A549 cells
b.  Chlorine-exposed mice 
(1.4-2.3x10−8 M or 12.5 
mg/mL)
a.  Inhibits IL-8 production and NF-κB 
activation
b.  Inhibits neutrophilic inflammation and the 
production of CXC chemokine KC (Cxcl1) 
(Hoyle et al., 2010)
Lung inflammation Ganoderma lucidum, 
Radix Sophorae 
flavescenti ,
Radix Glycyrrhiza
OVA or concanavalin A (ConA)- 
sensitized and challenged mice
(10 mg/day)
Reduces levels of IgE and the Th2 
cytokines(IL-4, IL-5, and IL-13) in lung 
and splenocyte cultures and increases IFN-γ 
secretion (Busse et al., 2010)
Pneumonia Polyphenol rich extract 
from M. officinalis  bark
(MPE)
Influenza virus A (IVA)-infected 
mice (10-20 mg/kg)
Reduces levels of serum NO, IL-6 and TNF-α, 
inhibits pneumonia and decreases lung viral 
titers through downregulation of NF-κB and 
TLR3 protein expressions in the lung tissue 
(Wu et al., 2011)
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Lung inflammation Pneumocystis carinii infected
rats (100-400 mg/kg/day)
Decreases the contents of TNF-α and soluble 
ICAM-1, and alleviate inflammation in lung 
tissues (Zhou and Zhou, 2009)
Joint diseases 
Arthritis Petroleum ether (PE),
ethyl acetate (EE) 
n-butyl alcohol (n-BE) 
and water (WE) were 
extracted from  ARCF 
rhizome
Type II bovine collagen (CII) 
-induced BALB/c mice
(ME 130, 261, 522 mg/kg; 
EE 10.2, 20.4, 40.8 mg/kg; 
n-BE 52, 104, 208 mg/kg)
Suppresses paws and joints swelling and 
reduced the spleen indexes and reduces serum 
levels of inflammatory cytokines TNF-α, IL-
1β, IL-6, IL-33 and rheumatoid factor (RF) 
(Chunxia et al., 2011)
Septic arthritis LPS-simulate chondrocytes 
(0.056-7.7 %)
Increases chondrocytes viability and 
extracellular matrix synthesis through 
inhibition of NO production, iNO, COX-2 and 
matrix metalloproteinase (MMP)–1, MMP-3, 
and MMP-13expressions (Liu et al., 2010a)
Arthritis Adjuvant-induced rats 
(50-100 mg/kg)
Inhibits paw swelling and articular index 
scores, and reduces IL-6, VEGF and fibroblast 
growth factor (FGF-2) expressions in rat 
synovial tissues (Pan et al., 2009b)
Arthritis
Synovial 
inflammation
Type II collagen-induced wistar 
rats (1-4 mg/kg)
Up-regulates nuclear Annexin-1expression and 
inhibits NF-κB activity in synovium, reduces 
IL-1β level and thereby depresse paw swelling
(Wang et al., 2011)
Pain Pogostemon cablin (PC) 
was  extracted with 
methanol 
a.  Acetic acid-induced writhing 
response 
b.  Formalin-induced paw licking
c.  γ-carrageenan (Carr)-induced 
mice paw edema (0.5-1.0 
g/kg)
Decreases malondialdehyde (MDA) level, 
COX-2 and TNF-α activities by increasing 
the activities of anti-oxidant enzymes, such 
as superoxide dismutase (SOD), glutathione 
peroxidase (GPx) and glutathione reductase 
(GRx) (Lu et al., 2009b)
Pain Pterocephalus hookeri 
(C.B. Clarke) was 
extracted with ethanol 
and aqueous 
a.  λ-carrageenan (Carr)-induced 
mice paw edema
b.  Cotton pellet-induced 
granuloma formation in rats
c. Acetic acid-induced mice
d.  Xylene-induced ear edema 
(1-4 g/kg)
Increases the hot-plate pain threshold and 
reduced writhing response, rat paw edema 
perimeter, vascular permeability and 
granuloma weight (Zhang et al., 2009)
Pain 
Rheumatoid arthritis
a.  Acetic acid-induced pain and 
Evans blue leakage in mice 
b. &arrageenan-induced mouse 
paw edema (25 and 50 mg/kg)
c.  LPS-stimulated RAW264.7 
cells (25-50 (g/mL)
Inhibits pain, Evans blue leakage, paw edema, 
NO production and iNOS expression (Zhang 
and Shi, 2010)
Pain Eudesmin, horsfieldin, 
fargesin, kobusin, 
sesamin, asarinin, 
planispine A,
and pinoresinol-di-3,3-
dimethylallyl 
a. Acetic acid-induced mice
b. Formalin induced mice 
c. Xylene-induced mice
(100 and 800 mg/kg)
Decreases writhing numbers, licking times and 
ear swelling
(Guo et al., 2011)
Pain
Edema
a. Carrageenan-induced rats
b. Xylene-induced mice
c. Acetic acid-induced and 
d. Hot-plate test model
(400 mg/kg)
Inhibits paw edema, ear edema, writhing and 
pain (Yi et al., 2010)
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Pain
Edema
a. Xylene-induced ear edema
b. Formaldehyde-induced rats
c. Acetic acid-induced mice
d.  LPS-stimulated peritoneal 
macrophages (1-5 mg/kg or 
0.0001-0.1 μg/mL)
Inhibits writhing response, ear swelling and 
paw edema and decreases PGE  production 
and COX-2 expression (Niu et al., 2011)
Pain
Edema
16-formyl-5α-
methoxystrictamine, 
picralinal and  
tubotaiwine were 
extracted with ethanol 
from Alstonia scholaris
a. Acetic acid-induced mice 
b.  Hot-plate and formalin tests 
in mice.
c. Xylene-induced and mice
d.  Carrageenan-induced air 
pouch formation in mice 
(50-100 mg/kg)
Reduces writhing response, ear edema, 
NO, PGE2 and MDA, COX-1, COX-2 and 
5-lipoxygenase (5-LOX) levels, and increases 
SOD activity (Shang et al., 2010)
Pain
Edema
a.  Xylene, acetic acid and 
carrageenan-induced models
b.  Leukocyte migration assay
c.  Cotton pellet granuloma 
models (35 mg/kg)
Decreases ear edema, vascular permeability, 
paw edema, MDA level, leukocyte count and 
granuloma tissue formation by increases the 
serum level of SOD (Wang et al., 2010)
Pain
Edema
Osteoarthritis
Dried leaves of M. 
exotica. was extracted 
with ethanol 
a.  Acetic acid, hot-plate, 
carrageena and xylene 
-induced models
b.  Rat knee osteoarthritis model 
(Ethanol 70% extracts)
Decreases writhing response, paw edema, ear 
swelling, iNOS activity, IL-1β and TNF-α 
contents, and increases SOD activity and hot-
plate pain latency (Wu et al., 2010)
Pain a.  Acetic acid-induced writhing 
response  
b.  Complete Freund's adjuvant 
(CFA)-induced rats 
c. Thermally induced mice
d.  Xylene-induced ear edema 
(90.6 mg/kg)
Reduces ear edema and writhing (Chen et al., 
2011)
Cutaneous diseases 
Skin inflammation Chrysanthemum 
indicum Linne (CIE) 
was extracted with 70% 
ethanol 
12-O-tetradecanoyl-phorbol-13-
acetate (TPA)-induced mouse 
ear edema (200 mg/kg)
Reduces skin thickness and tissue weight, 
inflammatory cytokine production (IL-1β and 
TNF-α), neutrophil-mediated myeloperoxidase 
(MPO) activity, and various histopathological 
indicators (Lee et al., 2009a)
Skin inflammation Asparagus 
cochinchinensis Merrill 
(ACE) was extracted 
with 70% ethanol
a.  TPA-induced mouse ear 
edema (200 mg/kg)
b.  Acetic acid-induced mice 
(200 mg/kg)
Reduces skin thickness and tissue weight, 
inflammatory cytokine production (IL-
1β and TNF-α), neutrophil-mediated MPO 
activity, vascular permeability and various 
histopathological indicators (Lee et al., 2009b)
Liver disease 
Alcoholic fatty liver 
disease (NAFLD)
Cinnamomum cassia 
blume, Paeonia lactiflora 
Pallas, Prunus persica 
Batsch, Poria cocos Wolf 
and Paeonia suffruticosa 
Andrews 
NASH animal model and 
patients
(Cinnamomi cortex 3 g
Paeoniae radix Pallas 3 g
Persicae semen Batsch 3 g
Hoelen 3 g
Moutan cortex 3 g)
Decreases liver injury and blood cholesterol 
(Fujimoto et al., 2010)
Non-alcoholic 
steatohepatitis 
(NASH)
Qu Yu Hua Tan
Tong Luo 
decoction 
(QYHTTLD)
NASH patients
(Radix Bupleuri 10 g
Radix Scutellariae 12 g
Rhizoma Pinelliae 10 g
Radix Codonopsis Pilosulae 
30 g, Radix Glycyrrhizae 
Praeparata 6g Fructus Ziziphi 
Jujubae 9 g, Rhizoma Polygoni 
Cuspidati 30gRadix Morindae
Officinalis 8 g, Herba Hedyotis
Diffusae 30 g)
Decreases IL-8, TNF-α and MDA levels and 
increases SOD activity (Zhang et al., 2008)
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Abbreviations
TCM traditional Chinese medicine
NF-κB nuclear factor-κB 
TNF-α tumor necrosis factor-α
CCL chemokine (C-C motif) ligand 
iNOS inducible nitric oxide synthase 
COX2 cyclooxygenase 2 
RO/NS reactive oxygen/nitrogen species 
IL interleukins
LPS lipopolysaccharide
PGE2 prostaglandin E2
NO nitric oxide
IFN-γ interferon-γ
MAPK mitogen-activated protein kinase 
PKC protein kinase C
AP-1 activator protein 1 
HIF-1α hypoxia-inducible factor-1α 
CNS central nervous system 
TGP otal glucosides of peony 
JNK c-Jun N-terminal kinases 
MEK3/6
MAPK extracellular signal-regulated kinases (ERK) 
kinase3/6 
CVD cardiovascular disease 
MPO myeloperoxidase 
ox-LDL oxidized low density lipoprotein 
VCAM-1 vascular cell adhesion molecule-1 
ICAM-1 intracellular adhesion molecule-1 
MCP-1 monocyte chemoattractant protein-1 
MMPs matrix metalloproteinases 
HUVEC human umbilical vein endothelial cells 
MIF migration inhibitory factor 
NOD nonobese diabetic 
RORγt etinoic acid-related orphan receptor γt 
AGEs advanced glycation end products 
TGF-β1 transforming growth factor-β1
RAGE receptor for advanced glycation end products 
VEGF vascular endothelial growth factor 
IBD inflammatory bowel disease 
UC ulcerative colitis 
ECs endothelial cells 
TNBS 2,4,6-trinitrobenzene sulfonic acid 
AHR airway hyperresponsiveness 
OVA ovalbumin 
TLR Toll like receptor 
IVA influenza virus A 
RA Rheumatoid arthritis 
RF rheumatoid factor 
FGF-2 fibroblast growth factor 
CFA complete Freund’s adjuvant 
CIE Chrysanthemum indicum 
ACE Asparagus cochinchinensis Merrill extract 
TPA 12-O-tetradecanoyl-phorbol-13-acetate
NASH non-alcoholic steatohepatitis
TGs triglycerides 
SOD superoxide dismutase 
GPx glutathione peroxidase 
GRx glutathione reductase
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